Relapse rates following cessation of che
β
Baum, E. ;Sather, H. ;Nachman, J. ;Seinfeld, J. ;Krivit, W. ;Leikin, S. ;Miller,
π
Article
π
1979
π
John Wiley and Sons
π
English
β 494 KB
The therapeutic benefit of maintenance chemotherapy beyond three years for children with acute lymphocytic leukemia (ALL) in continuous complete remission was evaluated by the investigators of Childrens Cancer Study Group (CCSG). Two hundred and twenty leukemic children in first remission for three